News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
132,624 Results
Type
Article (9098)
Company Profile (23)
Press Release (123502)
Multimedia
Podcasts (13)
Webinars (4)
Section
Business (30195)
Career Advice (197)
Deals (3999)
Drug Delivery (21)
Drug Development (30898)
Employer Resources (23)
FDA (3831)
Job Trends (3455)
News (68017)
Policy (5941)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
Academia (870)
Accelerated approval (7)
Adcomms (5)
Allergies (50)
Alliances (8579)
ALS (73)
Alzheimer's disease (757)
Antibody-drug conjugate (ADC) (72)
Approvals (4030)
Artificial intelligence (153)
Autoimmune disease (47)
Automation (9)
Bankruptcy (34)
Best Places to Work (3352)
Biosimilars (45)
Biotechnology (13)
Bladder cancer (40)
Brain cancer (20)
Breast cancer (209)
Cancer (1460)
Cardiovascular disease (146)
Career advice (183)
Career pathing (9)
CAR-T (54)
CDC (5)
Celiac Disease (1)
Cell therapy (161)
Cervical cancer (10)
Clinical research (29207)
Collaboration (437)
Compensation (46)
Complete response letters (9)
COVID-19 (883)
CRISPR (27)
C-suite (256)
Cystic fibrosis (74)
Data (2486)
Denatured (7)
Depression (49)
Diabetes (165)
Diagnostics (1192)
Digital health (7)
Diversity (3)
Diversity, equity & inclusion (8)
Drug discovery (67)
Drug pricing (25)
Drug shortages (3)
Duchenne muscular dystrophy (63)
Earnings (10675)
Editorial (15)
Employer branding (3)
Employer resources (23)
Events (16490)
Executive appointments (245)
FDA (4804)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (10)
Funding (496)
Gene editing (45)
Generative AI (16)
Gene therapy (179)
GLP-1 (245)
Government (1008)
Grass and pollen (1)
Guidances (77)
Healthcare (4330)
HIV (33)
Huntington's disease (11)
IgA nephropathy (45)
Immunology and inflammation (59)
Immuno-oncology (15)
Indications (41)
Infectious disease (975)
Inflammatory bowel disease (71)
Inflation Reduction Act (2)
Influenza (38)
Intellectual property (62)
Interviews (22)
IPO (2072)
IRA (5)
Job creations (302)
Job search strategy (149)
JPM (6)
Labor market (10)
Layoffs (66)
Leadership (10)
Legal (935)
Liver cancer (21)
Longevity (4)
Lung cancer (239)
Lymphoma (111)
Machine learning (15)
Management (4)
Manufacturing (143)
MASH (49)
Medical device (1858)
Medtech (1868)
Mergers & acquisitions (2087)
Metabolic disorders (367)
Multiple sclerosis (75)
NASH (6)
Neurodegenerative disease (122)
Neuropsychiatric disorders (21)
Neuroscience (1306)
NextGen: Class of 2026 (1367)
Non-profit (3062)
Now hiring (6)
Obesity (143)
Opinion (74)
Ovarian cancer (74)
Pain (59)
Pancreatic cancer (47)
Parkinson's disease (162)
Partnered (6)
Patents (122)
Patient recruitment (196)
Peanut (31)
People (10695)
Pharmaceutical (8)
Pharmacy benefit managers (2)
Phase 1 (6629)
Phase 2 (12763)
Phase 3 (11608)
Pipeline (1673)
Policy (40)
Postmarket research (913)
Preclinical (1685)
Press Release (19)
Prostate cancer (85)
Psychedelics (11)
Radiopharmaceuticals (49)
Rare diseases (288)
Real estate (633)
Recruiting (9)
Regulatory (5361)
Reports (6)
Research institute (812)
Resumes & cover letters (22)
Rett syndrome (9)
RSV (33)
Schizophrenia (77)
Series A (76)
Series B (55)
Sickle cell disease (27)
Special edition (1)
Spinal muscular atrophy (92)
Sponsored (11)
Startups (700)
State (1)
Stomach cancer (2)
Supply chain (16)
Tariffs (7)
The Weekly (6)
Vaccines (282)
Venture capital (19)
Weight loss (87)
Women's health (22)
Worklife (3)
Date
Today (1)
Last 7 days (137)
Last 30 days (634)
Last 365 days (7935)
2026 (819)
2025 (7854)
2024 (8136)
2023 (9256)
2022 (10749)
2021 (12367)
2020 (12497)
2019 (10394)
2018 (7834)
2017 (6376)
2016 (6418)
2015 (7066)
2014 (4843)
2013 (3385)
2012 (3539)
2011 (3761)
2010 (2956)
Location
Africa (188)
Alabama (20)
Alaska (4)
Arizona (44)
Arkansas (2)
Asia (7969)
Australia (1457)
California (2687)
Canada (652)
China (293)
Colorado (119)
Connecticut (175)
Delaware (113)
Europe (19059)
Florida (373)
Georgia (133)
Hawaii (1)
Idaho (12)
Illinois (171)
India (13)
Indiana (214)
Iowa (8)
Japan (173)
Kansas (25)
Kentucky (13)
Louisiana (5)
Maine (5)
Maryland (307)
Massachusetts (1983)
Michigan (61)
Minnesota (73)
Missouri (38)
Montana (14)
Nebraska (8)
Nevada (43)
New Hampshire (14)
New Jersey (930)
New Mexico (7)
New York (776)
North Carolina (263)
North Dakota (2)
Northern California (1430)
Ohio (70)
Oklahoma (5)
Oregon (8)
Pennsylvania (545)
Puerto Rico (3)
Rhode Island (7)
South America (183)
South Carolina (4)
South Dakota (1)
Southern California (947)
Tennessee (29)
Texas (408)
United States (9701)
Utah (77)
Virginia (54)
Washington D.C. (22)
Washington State (210)
West Virginia (1)
Wisconsin (17)
132,624 Results for "foundation fighting blindness".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation
The Novo Nordisk Foundation’s funds will go toward supporting early-stage companies working in “human health, planetary health and societal resilience.”
January 16, 2026
·
2 min read
·
Tristan Manalac
Drug Development
Opus Genetics Announces $1.7 Million in Project-based Funding from the Foundation Fighting Blindness to Support Two Preclinical Programs
Opus Genetics, a patient-first, clinical-stage gene therapy company developing treatments for inherited retinal diseases, announced it has received $1.7 million in project-based funding from the Foundation Fighting Blindness to help advance two preclinical candidate programs.
June 13, 2024
·
3 min read
FDA
UPDATE: Tidmarsh Waffles on Resignation, Will Fight To Clear Name
Less than 24 hours after resigning his post as the FDA’s head drug regulator, George Tidmarsh is reportedly reconsidering his decision and vowing to fight for his name and credibility amid a probe into his “personal conduct” at the agency.
November 3, 2025
·
3 min read
·
Tristan Manalac
C-suite
UPDATE: Novo Foundation Completes Board Takeover After Shareholder Pushback
“As the future chair I will attend to the interests of not only the Novo Nordisk Foundation but all shareholders of the company,” incoming chair and former Novo Nordisk CEO Lars Rebien Sørensen said at the meeting held Friday.
November 14, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment
December 18, 2025
·
6 min read
Press Releases
Bacterial Mechanism That Could Help Prevent and Treat Lyme Arthritis Identified by New Bay Area Lyme Foundation–Supported Study
January 21, 2026
·
4 min read
Podcast
Pfizer and Novo Battle Over Metsera, Tidmarsh Fights FDA Exit, UniQure and Sarepta Face Setbacks
Pfizer and Novo Nordisk continue to fight for ownership of obesity startup Metsera; CDER Director George Tidmarsh leaves his position amid an ongoing probe into his “personal conduct”; FDA reverses course on approval requirements for uniQure’s Huntington’s gene therapy; Sarepta’s exon-skipping Duchenne muscular dystrophy drugs fail confirmatory study.
November 5, 2025
·
1 min read
·
Heather McKenzie
Press Releases
Foundation Fighting Blindness and Usher III Initiative Partner to Launch a Natural History Study for Usher Syndrome Type 3
August 14, 2024
·
3 min read
BioCapital
Foundation Fighting Blindness to Host PRPH2 and Associated Retinal Diseases Workshop
The Foundation Fighting Blindness will host the free in-person PRPH2 and Associated Retinal Diseases Workshop on March 29–31, 2023, at the Hilton La Jolla Torrey Pines in San Diego, CA.
January 25, 2023
·
4 min read
Press Releases
Opus Genetics Featured on Good Morning America Spotlighting Breakthrough Gene Therapy Restoring Sight in Patients with Inherited Blindness
November 4, 2025
·
4 min read
1 of 13,263
Next